- Home
- SILO vs YCBD Comparison
SILO vs YCBD Comparison
Compare SILO & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- YCBD
- Stock Information
- Founded
- SILO 2010
- YCBD 2015
- Country
- SILO United States
- YCBD United States
- Employees
- SILO N/A
- YCBD N/A
- Industry
- SILO Apparel
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- YCBD Health Care
- Exchange
- SILO Nasdaq
- YCBD Nasdaq
- Market Cap
- SILO 8.0M
- YCBD 7.8M
- IPO Year
- SILO N/A
- YCBD N/A
- Fundamental
- Price
- SILO $0.54
- YCBD $0.87
- Analyst Decision
- SILO
- YCBD Strong Buy
- Analyst Count
- SILO 0
- YCBD 1
- Target Price
- SILO N/A
- YCBD $2.00
- AVG Volume (30 Days)
- SILO 869.8K
- YCBD 531.7K
- Earning Date
- SILO 11-12-2025
- YCBD 12-17-2025
- Dividend Yield
- SILO N/A
- YCBD N/A
- EPS Growth
- SILO N/A
- YCBD N/A
- EPS
- SILO N/A
- YCBD N/A
- Revenue
- SILO $72,102.00
- YCBD $19,026,064.00
- Revenue This Year
- SILO $1.86
- YCBD $0.37
- Revenue Next Year
- SILO N/A
- YCBD $4.95
- P/E Ratio
- SILO N/A
- YCBD N/A
- Revenue Growth
- SILO N/A
- YCBD N/A
- 52 Week Low
- SILO $0.40
- YCBD $0.59
- 52 Week High
- SILO $3.37
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- SILO 40.10
- YCBD 40.68
- Support Level
- SILO $0.50
- YCBD $0.94
- Resistance Level
- SILO $0.59
- YCBD $1.09
- Average True Range (ATR)
- SILO 0.05
- YCBD 0.13
- MACD
- SILO -0.00
- YCBD -0.05
- Stochastic Oscillator
- SILO 54.31
- YCBD 4.45
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.